(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RARE DISEASE DIFFERENCE MAKER

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

RARE DISEASE DIFFERENCE MAKER

ST13

US500000087665436

Class

35

Filing

87665436

Registration

5591699

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

06/26/2024

Trademark type

Combined

Nice classes

35

Filing date

10/30/2017

Registration date

10/23/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/26/2024

Last transaction

06/26/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/27/2018

First use in commerce

04/27/2018

Drawing code

3

Owner type

03

Owner location

Eagan, MN

Examiner

RINKER, ANTHONY MICHAEL

Current location

Historical data usage

Mark description

The mark consists of the words "RARE DISEASE DIFFERENCE MAKER" with the letter "M" forming a representation of a human being.

Holders and representatives

Holders

Engage Health, Inc.

Representatives

Stephen R. Baird Greenberg Traurig, LLP

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Advertising and marketing servicespromoting the goods and services of others; Advertisingmarketing and promotion services; Collection of market research information; Consumer research; Marketing services for the medical goods and services of others; Promoting medical professionals and medical goods and services for others; Providing consumer information in the field of medicinedoctorsmedical professionals; Providing information in the field of the medical industry

Publications

History of USPTO decisions and trademark events.

30 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/26/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/26/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/26/2024

E815

TEAS SECTION 8 & 15 RECEIVED

12/14/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/23/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/11/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

10/23/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/19/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/18/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/28/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/28/2018

IUAF

USE AMENDMENT FILED

07/30/2018

EISU

TEAS STATEMENT OF USE RECEIVED

07/30/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/22/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/27/2018

PUBO

PUBLISHED FOR OPPOSITION

03/27/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/07/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/20/2018

ALIE

ASSIGNED TO LIE

02/19/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/05/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/02/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/02/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/02/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/23/2018

GNRT

NON-FINAL ACTION E-MAILED

01/23/2018

CNRT

NON-FINAL ACTION WRITTEN

01/23/2018

DOCK

ASSIGNED TO EXAMINER

01/16/2018

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/09/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/08/2017

NWAP

NEW APPLICATION ENTERED

11/02/2017

Continuous trademark protection

Get notified about every new filing that threatens RARE DISEASE DIFFERENCE MAKER or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.